Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | -0.69% | -11.59% | -58.33% |
Chart calendar Altamira Therapeutics
Upcoming events on Altamira Therapeutics
Past events on Altamira Therapeutics
10/04/2024 13:30 | Q4 2023 Earnings Call |
10/04/2024 13:00 | Q4 2023 Earnings Release |
22/01/2024 | MRNA Based Therapeutics Summit |
11/12/2023 13:30 | Business Update Call |
12/09/2023 13:00 | Q2 2023 Earnings Call |
12/09/2023 12:30 | Q2 2023 Earnings Release |
11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
20/03/2023 | RNAi Based Therapeutics Summit |
25/02/2023 15:45 | American Academy of Allergy, Asthma & Immunology Meeting |
17/02/2023 12:30 | Extraordinary Shareholders Meeting |
07/02/2023 | RNA Therapeutics Conference |
23/01/2023 | mRNA-Based Therapeutics Summit Europe Conference |
30/11/2022 13:47 | Interim 2022 Earnings Release |
15/11/2022 | TIDES Europe Event |
17/10/2022 | RNA Leaders USA Congress |
25/09/2022 | RAS-Targeted Drug Development Summit |
14/09/2022 15:30 | Business Update Call |
24/05/2022 12:00 | H.C. Wainwright Global Life Sciences Investment Conference |
12/04/2022 13:00 | FY 2021 Earnings Call |
12/04/2022 12:30 | FY 2021 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 |
EBITDA Million CHF | Released Forecast Spread | -7,23 -11,0 33.99% | 0,00 | 0,00 |
EBIT Million CHF | Released Forecast Spread | -7,26 -10,6 31.76% | 0,00 | -7,85 |
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -6,83 -10,7 36.24% | 0,00 | 0,00 |
Net income Million CHF | Released Forecast Spread | -6,63 -9,31 28.74% | -3,87 | 0,00 |
EPS CHF | Released Forecast Spread | -912 -1 338 31.84% | -7,88 | 0,00 |
Announcement Date | 16/04/20 | 10/04/24 | - |
Quarterly results
Fiscal Period | December | 2019 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
---|---|---|---|---|---|---|
Net sales Million CHF | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million CHF | Released Forecast Spread | -3,15 -5,23 39.68% | ||||
Net income Million CHF | Released Forecast Spread | -3,03 -4,83 37.25% | ||||
EPS CHF | Released Forecast Spread | -248 -588 57.82% | ||||
Announcement Date | 16/04/20 | - | - | - | - |
Today 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
14/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
15/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 14:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
23/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
24/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
25/07/2024 06:00 | ARGENX SE: Q2 2024 Earnings Release |
29/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
29/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
29/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Altamira Therapeutics
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CYTO Stock
- CYTO Stock
- Calendar Altamira Therapeutics